Search - tctmd.com

Displaying 81 - 100 of 237

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Presenter: Howard C. Herrmann, Fabian Nietlispach, Futoshi Yamanaka, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Presenter: Howard C. Herrmann, Fabian Nietlispach, Mohamad Lazkani, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Presenter: Howard C. Herrmann, Fabian Nietlispach, Roberto Spina, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Periprocedural Transaortic Valve LVOT Migration With Successful Reposition: "The Double-Snare Technique

Presenter: Howard C. Herrmann, Fabian Nietlispach, Matja Bunc, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease

Presenter: Howard C. Herrmann, Fabian Nietlispach, Marc Gerdisch, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

Presenter: Howard C. Herrmann, Fabian Nietlispach, Chandan Devireddy, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Sub-Xiphoid Trans-Aortic TAVI in a Patient With Severe Arterial Calcifications

Presenter: Howard C. Herrmann, Fabian Nietlispach, Matja Bunc, MD

June 21, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Shelley Wood

March 07, 2018

Presentation TCT 2017

Aortic Valve Replacement for CHF

Presenter: Daniel Burkhoff, JoAnn Lindenfeld, Howard C. Herrmann

October 31, 2017

Presentation TCT 2017

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Presenter: Howard C. Herrmann, Michael J. Mack

October 31, 2017

Presentation TCT 2017

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Francesco Maisano

October 31, 2017

Presentation TCT 2017

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, David Meerkin

October 31, 2017

Presentation TCT 2017

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Maurice Buchbinder

October 31, 2017

Presentation TCT 2017

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Presenter: Howard C. Herrmann, Michael J. Mack, Philippe Genereux

October 31, 2017

Presentation TCT 2017

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Mathew Williams

October 31, 2017

Presentation TCT 2017

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Nicolo Piazza

October 31, 2017

Presentation TCT 2017

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Vinayak Bapat

October 31, 2017

Presentation TCT 2017

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, David W.M. Muller

October 31, 2017

Presentation TCT 2017

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Presenter: Howard C. Herrmann, Michael J. Mack, Anson Cheung

October 31, 2017

Advertisement

Subtotal Left Main Occlusion Two Days After Transcatheter Aortic Valve Replacement in Severe Bicuspid Aortic Stenosis

Coronary Occlusion Following Self-Expandable Transcatheter Aortic Valve Replacement in Native Aortic Valve Regurgitation

Acute Left Main Stem Coronary Occlusion Following Transcatheter Aortic Valve Replacement in a Patient Without Recognized Coronary Obstruction Risk Factors

Periprocedural Transaortic Valve LVOT Migration With Successful Reposition: "The Double-Snare Technique

Hybrid Beating Coronary Artery Bypass Grafting and Transcatheter Aortic Valve Replacement via Right Carotid Artery Access in a Patient With Severe Peripheral Arterial Disease

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

Sub-Xiphoid Trans-Aortic TAVI in a Patient With Severe Arterial Calcifications

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Results for Dock-Plus-Valve Approach Promising in Transcatheter Mitral Valve Replacement

Aortic Valve Replacement for CHF

Musings on TMVR Patient Selection Criteria to Date, and Which Patients Should Be Put in TMVR Trials Rather Than Treated Clinically With Current Devices

Emerging TMVR 5: Mitraltech - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 4: Corona Valve With Amend Ring - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 3: M-Dock - Device Description, Critical Appraisal, and Development Plans

Emerging TMVR 2: 4C - Device Description, Critical Appraisal, and Development Plans

Established TMVR 6: Caisson - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 5: Highlife - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 4: Intrepid - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 3: Tendyne - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Established TMVR 2: Tiara - Device Description, Strengths and Weaknesses, and Updated Summary Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content